Why are we waiting? - Pressures facing the NHS and how to deliver change

Pharma Market Access Insights - from Petauri Evidence

Content provided by Petauri Evidence. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Petauri Evidence or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

2+ y ago 1:00:47

MP3•Episode home

Send us a text

With so many patients left waiting for NHS care, what will the long-term impact be? How can Pharma and Medtech support the NHS with systematic challenges, like waiting? Where can industry work with the NHS to improve patient flow to get people appropriate treatment sooner and limit the harm caused by waiting? Prof Phil Richardson (new Chief Innovation Officer, Mtech Access and until recently, Executive Director at NHS Dorset ICS) joins Tom Clarke (Director, Mtech Access) explored all this and more.
In this NHS Whispers webinar, we explore:
- The pressures facing NHS systems and how this results in patients waiting
- The long-term impact of this waiting; what it means for patients, their - outcomes and treatment
- What informs how NHS system leaders identify and approach these challenges
- How health and care systems can make effective decisions in this climate
- How Pharma and Medtech can support system leaders with these challenges
This webinar was first broadcast as a live webinar in November 2022. Learn more.
Discover more about our NHS Insight and Interaction services.
Subscribe to our newsletter to hear more news, insights and events from Petauri Evidence

Chapters

1. Why are we waiting? - Pressures facing the NHS and how to deliver change (00:00:00)

2. Prof Phil Richardson - can you introduce yourself and share more about your background? (00:02:22)

3. How do you see integrated care systems progressing? (00:05:35)

4. What do you see as the key challenges that will impede patient care over the next 6 to 12 months? (00:12:04)

5. From a broader system perspective, what are the impacts of increased waiting? (00:17:50)

6. What's could be the impact of removing waiting from the system? (00:22:09)

7. What data do you have access to give you that full picture? (00:25:54)

8. How can systems and their partners approach some of these challenges caused by waiting? (00:32:49)

9. How are decisions made about what to focus on? (00:38:20)

10. What role do you see academia and research playing? (00:50:06)

11. What are the key takeaways for our audience in terms of how they can support the NHS and reduce the amount of waiting going on? (00:55:10)

69 episodes

#Science #Fitness #Biology #Business #Medicine #Mtech Access #Pharmaceutical #Pharma #Market Access #Health Economics #Heores #Medtech #NHS #Healthcare